type-2-diabetes-mellitus

Documents about type-2-diabetes-mellitus

• A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes#175070ClinicalTrials.gov
• Examination of Psychological Tools and Tracking in an Online Intervention for Type 2 Diabetes#234561ClinicalTrials.gov
• Effects of Empagliflozin-Metformin, Sitagliptin-Metformin, and Metformin on Adipokines in Type 2 Diabetes#252956ClinicalTrials.gov
• A Study of LY3209590 in Healthy Participants and Participants With Type 2 Diabetes#257064ClinicalTrials.gov
• A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus#127816ClinicalTrials.gov
• Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus#216986ClinicalTrials.gov
• The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction#123654ClinicalTrials.gov
• Diabetes Lifestyle Assessment and Educational Tools#127759ClinicalTrials.gov
• Low dosE GlibENclamide in Diabetes Part A#158183ClinicalTrials.gov
• Rowing Away From Diabetes#195522ClinicalTrials.gov
• Impact of Pharmacy Clinic on Diabetes Management#234496ClinicalTrials.gov
• Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes#126058ClinicalTrials.gov
• Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)#127827ClinicalTrials.gov
• A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus#136218ClinicalTrials.gov
• A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus#136297ClinicalTrials.gov
• The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus Patients#152369ClinicalTrials.gov
• A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Monotherapy#172534ClinicalTrials.gov
• Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea#252949ClinicalTrials.gov
• Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes#141167ClinicalTrials.gov
• Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes#162430ClinicalTrials.gov
• Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes#216983ClinicalTrials.gov
• RCT Glargine vs NPH for Treatment of DM in Pregnancy#171298ClinicalTrials.gov
• SIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabetes Mellitus Type 2#28522ClinicalTrials.gov
• A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control#136285ClinicalTrials.gov
• Evaluation of a Closed-loop System for the Treatment of Type 2 Diabetes at Home (DT2_2)#146363ClinicalTrials.gov
• A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes#67818ClinicalTrials.gov
• Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)#146405ClinicalTrials.gov
• Metformin Effects on Oxidative Stress Parameters in Newly Diagnosed Type 2 Diabetes Patients#148711ClinicalTrials.gov
• Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes#154829ClinicalTrials.gov
• Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes#154872ClinicalTrials.gov
• Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin#160297ClinicalTrials.gov
• Dietary Intervention Modifies Gut Microbiota in Type 2 Diabetes.#162389ClinicalTrials.gov
• Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes#180358ClinicalTrials.gov
• The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians#181680ClinicalTrials.gov
• Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin#195520ClinicalTrials.gov
• Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet#208400ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes#216984ClinicalTrials.gov
• Comparative Cardiovascular Effectiveness of GLP-1 RAs vs. Insulin in Early-Onset Type 2 Diabetes#226229ClinicalTrials.gov
• Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy#249552ClinicalTrials.gov
• Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes#261459ClinicalTrials.gov
• Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects#261480ClinicalTrials.gov
• Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan#267977ClinicalTrials.gov
• A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus#249510ClinicalTrials.gov
• Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin#6830OpenAlex
• Regulatory Request NIS in Korea#127838ClinicalTrials.gov
• Avandamet Bioequivalence Study Brazil - Fed Administration#201745ClinicalTrials.gov
• Medically Reproducing Bariatric Surgery#245473ClinicalTrials.gov
• A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes#201692ClinicalTrials.gov
• Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.#127806ClinicalTrials.gov
• Estimation of Glomerular Filtration Rate (GFR) in Patients With Type 2 Diabetes Mellitus.#136240ClinicalTrials.gov